Real-time enrollment status for this metastatic renal cell carcinoma ( mrcc) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:47 AM UTC
| NCT Number | NCT06601296 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Renal Cell Carcinoma ( mRCC) |
| Phase | PHASE2 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Texas Southwestern Medical Center |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of July 18, 2026: Clinical trial NCT06601296 is currently recruiting participants. This phase2 study for metastatic renal cell carcinoma ( mrcc) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Texas Southwestern Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06601296 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06601296 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.